Alpha 2.0
Login Register
» Articles » PMID: 34514186

Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients

Overview
Journal Kidney Int Rep
Publisher Elsevier
Specialty Nephrology
Date 2021 Sep 13
PMID 34514186
Citations 5
Authors
Esther C Liu
Jennifer H Lee
Angela Loo
Shawn Mazur
Sam Sultan
Meredith Aull
Jun B Lee
Thangamani Muthukumar
Choli Hartono
Affiliations
Soon will be listed here.
Citing Articles

Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies.

Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T Intern Med. 2024; 63(16):2283-2287.

PMID: 38171874 PMC: 11414357. DOI: 10.2169/internalmedicine.2900-23.

How to use COVID-19 antiviral drugs in patients with chronic kidney disease.

Kale A, Shelke V, Dagar N, Anders H, Gaikwad A Front Pharmacol. 2023; 14:1053814.

PMID: 36843922 PMC: 9947246. DOI: 10.3389/fphar.2023.1053814.

Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough SARS-CoV-2 Infection.

Fahim P, Nicolaysen A, Yabu J, Zuckerman J Kidney Med. 2022; 4(7):100492.

PMID: 35637695 PMC: 9134749. DOI: 10.1016/j.xkme.2022.100492.

The "Invisible Enemy" SARS-CoV-2: Viral Spread and Drug Treatment.

Tanase A, Manea A, Scurtu A, Bratu L, Chioran D, Dolghi A Medicina (Kaunas). 2022; 58(2).

PMID: 35208584 PMC: 8875987. DOI: 10.3390/medicina58020261.

COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.

Dhand A, Razonable R Curr Transplant Rep. 2022; 9(1):26-34.

PMID: 35070639 PMC: 8760599. DOI: 10.1007/s40472-022-00357-2.